Nuvation Bio

$3.08 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Nuvation Bio

Nuvation Bio Inc. operates as a bio-pharmaceutical company. The Company focuses on developing oncology medicines that will improve patient lives by addressing drug resistance. Nuvation Bio serves patients worldwide.

Stock Analysis

last close $2.88
1-mo return -17.5%
3-mo return -26.5%
avg daily vol. 1.4M
52-week high 10.45
52-week low 2.25
market cap. $629M
forward pe -
annual div. -
roe -13.9%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 75.5%
baraka

Subscribe now for daily local and international financial news

Subscribe